Unknown

Dataset Information

Targeting a bacterial DNABII protein with a chimeric peptide immunogen or humanised monoclonal antibody to prevent or treat recalcitrant biofilm-mediated infections.


ABSTRACT:

Background

Chronic and recurrent bacterial diseases are recalcitrant to treatment due to the ability of the causative agents to establish biofilms, thus development of means to prevent or resolve these structures are greatly needed. Our approach targets the DNABII family of bacterial DNA-binding proteins, which serve as critical structural components within the extracellular DNA scaffold of biofilms formed by all bacterial species tested to date. DNABII-directed antibodies rapidly disrupt biofilms and release the resident bacteria which promote their subsequent clearance by either host immune effectors or antibiotics that are now effective at a notably reduced concentration.

Methods

First, as a therapeutic approach, we used intact IgG or Fab fragments against a chimeric pept

SUBMITTER: Novotny LA 

PROVIDER: S-EPMC7502671 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature